PPT-1 1 3.2.S.3.2 Impurities,

Author : briana-ranney | Published Date : 2016-05-10

Malaysia 29 September 2011 Impurities Dr Antony Fake WHO Prequalification Team Medicines Introduction This presentation is made with reference to the preparation

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "1 1 3.2.S.3.2 Impurities," is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

1 1 3.2.S.3.2 Impurities,: Transcript

Malaysia 29 September 2011 Impurities Dr Antony Fake WHO Prequalification Team Medicines Introduction This presentation is made with reference to the preparation of the API This is because the API is the source of the majority of impurities. 4 PHARMACEUTICAL IMPURITY ANALYSIS Water containing soluble impurities no impurities which might alter or damage the 1851-1900s. POP, semi-glossy surface; thin paper support, usually on heavy highlights; usually yellowed in highlights; paper fibers visible through album Joshua J. Coon. U. Wisconsin-Madison. Isobaric Tagging. Ross,PL. . et al. . MCP. . 2004. iTRAQ. Structure. Available Reagents. Phosphorylation. site on LIN28. Contemporary proteomics. Introduction of internal standard. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) July 2006 ICH Re ICH Topic Q3A (R) – Revised Guidelines in Oct-2006.. الشوائب في الأدوية الجديدة . Contents. 1. . Preamble . . 2. Classification of . Impurities . 3. Rationale for the Reporting and Control of Impurities . Dr. Christian Zeine, . Warsaw. , Nov 18, 2014. Science. . for a safer world. Topics . of. . today‘s. talk. Fundamental . guidelines. . from. ICH. Influence. . of. ICH . impurity. . guidelines. 4. -recuperation unit for the CSC of CMS. Conseil Européen pour la Recherche Nucléaire (CERN).. Fontys Hogescholen . Date: . 08 November 2010. Sander . Rouwette. Table of Contents. Introduction to CERN. \n \n\r \n \n\r and impurities to the surface as dross. This was skimmed off and the remaining clean tin ladled into moulds to cool and solidify ready f Is impurity greaterthan identification thresholda? Yes No No action Structure known human Yes identified? relevant risksb? No No Greater NoReduce than qualification safe level to not more than No Malaysia, 29 September 2011. Impurities. Dr Antony . Fake. WHO Prequalification . Team - Medicines. Introduction. This presentation is made with reference to the preparation of the API.. This is because the API is the source of the majority of impurities.. By . S . S. D BHAVANI RAJA. ASSISTANT PROFESSOR . DEPARTMENT. OF . PHARMACEUTICAL CHEMISTRY. Sources of Impurities. Department of Pharmaceutical Chemistry. Sources of Impurities. Impurity:-. Any substance coexisting with the original drug such as starting material or intermediate or that is formed due to any side reactions.. Scientific™ Orbitrap Exploris™ . 120 MS. Hao Yang, Ph.D.. Sr. Application Scientist. Biopharma and Pharma Vertical Marketing. Application: Nitrosamine impurities analysis. 2. Liquid chromatography high resolution mass spectrometry (LC-HRMS) method for NAs detection and quantitation. Cristian SAMPAOLESI. Certification of Substances Department (DCEP). EDQM, Council of Europe. 22 November 2019, Pavia - Italy. Deficiencies: How to avoid them ?. Reference documents. PA/PH/CEP (04) . 1, 6R (December 2018).

Download Document

Here is the link to download the presentation.
"1 1 3.2.S.3.2 Impurities,"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.